Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Twelve Month Follow-Up of CP0108

ClinicalTrials.gov ID: NCT02209012

Public ClinicalTrials.gov record NCT02209012. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Twelve Month Follow-Up Evaluation of Subjects Participating in DUSA-CP0108 (A Phase 3 Study of Photodynamic Therapy With Levulan Kerastick Topical Solution + Blue Light Versus Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the long-term safety and efficacy of Levulan PDT in subjects with multiple actinic keratosis of the upper extremities who received treatment as part of the DUSA CP0108 study.

Study identification

NCT ID
NCT02209012
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
DUSA Pharmaceuticals, Inc.
Industry
Enrollment
206 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2014 (Type not available)
Primary completion
Feb 2016 (Actual)
Completion
Apr 2016 (Actual)
Last update posted
Sep 23, 2016

2014 – 2016

United States locations

U.S. sites
13
U.S. states
8
U.S. cities
13
Facility City State ZIP Site status
Center For Dermatology Clinical Research, Inc. Fremont California 94538 —
UCSD Dermatology San Diego California 92122 —
Center for Clinical and Cosmetic Research Aventura Florida 33180 —
MOORE Clinical Research, Inc Brandon Florida 33609 —
Spencer Clinical Services St. Petersburg Florida 33716 —
Altman Dermatology Associates Arlington Heights Illinois 60005 —
Shideler Clinical Research Center Carmel Indiana 46032 —
The Indiana Clinical Trials Center, PC Plainfield Indiana 46168 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
J&S Studies, Inc College Station Texas 77845 —
Suzanne Bruce and Associates, P.A.,The Center for Skin Research Houston Texas 77056 —
Virginia Clinical Research, Inc. Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02209012, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2016 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02209012 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →